Video Presentations

Please select the presentation you would like to view.

Prehypertension: To Treat or Not to Treat
By Joel M. Neutel, MD

• PART I: Hypertension and Prehypertension: Classifications and
  Associated Risk (8:19)
  This presentation provides an overview of the JNC7 prehypertension classification, as well as research indicating that CVD risk increases incrementally with even mild BP elevations.
• PART II: The Role of Family History of Hypertension (10:00)
  This presentation summarizes research demonstrating the association between a family history of hypertension and altered metabolic, endocrine, and renal parameters in both normotensive and hypertensive adults.
• PART III: Endothelial Dysfunction, Hypertension, and Atherosclerosis (4:08)
  This presentation discusses factors that can lead to increased angiotensin II and decreased nitric oxide (NO); these can lead to elevated BP, endothelial dysfunction, and atherosclerosis.
• PART IV: BP Reduction in Hypertensive and Prehypertensive Patients:
  Treatments and Benefits (12:11)
  This presentation provides an overview of the benefits of pharmacologic BP reduction and lifestyle intervention in hypertension, as well as a discussion of pharmacologic and nutraceutical BP treatment in prehypertension.
• Case Study with Real-Time Voting

The Impact of Dietary Supplements on Hypertension
By Sheldon Saul Hendler, PhD, MD

• PART I: Diet and Dietary Supplements (27:21)
  This presentation examines the role of a healthy diet in BP control, as well as available evidence regarding the BP-lowering efficacy of a number of vitamins, minerals, herbs, and other dietary supplements.
• PART II: RAAS, ACE Inhibition, and Natural Supplementation (17:37)
  This presentation details the roles of the renin-angiotensin-aldosterone system (RAAS) and angiotensin-converting enzyme (ACE) inhibition in BP control, followed by a discussion of ACE-inhibitory food peptides and their efficacy in patients with hypertension and prehypertension.

Alternative Approaches to RAAS Blockade
By Joel M. Neutel, MD

• PART I: Alternative Approaches to RAAS Blockade (19:37)
  This presentation discusses the role of the RAAS in hypertension and CVD, followed by a discussion of the potential role of RAAS-mediated nutraceutical supplementation as a pathway to BP control.


• Case Study with Real-Time Voting